Celldex Therapeutics, Inc. Foreign Income Tax Expense (Benefit), Continuing Operations
Celldex Therapeutics, Inc. (CLDX) reported Foreign Income Tax Expense (Benefit), Continuing Operations of -$913.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2021-03-29.
Discontinued › Expense Statement › Income Tax
us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations · last filed 2021-03-29
- Celldex Therapeutics, Inc. foreign income tax expense (benefit), continuing operations for fiscal 2018 was -$913.00K.
- Celldex Therapeutics, Inc. foreign income tax expense (benefit), continuing operations for fiscal 2017 was -$2.45M.
- Celldex Therapeutics, Inc. foreign income tax expense (benefit), continuing operations for fiscal 2016 was -$1.12M.
- Celldex Therapeutics, Inc. foreign income tax expense (benefit), continuing operations for fiscal 2011 was -$84.00K.
| Period end | Foreign Income Tax Expense (Benefit), Continuing Operations 12 month |
|---|---|
| 2018-12-31 | -$913.00K 10-K · filed 2021-03-29 |
| 2017-12-31 | -$2.45M 10-K · filed 2020-03-26 |
| 2016-12-31 | -$1.12M 10-K · filed 2019-03-07 |
| 2011-12-31 | -$84.00K 10-K · filed 2014-03-03 |
| 2010-12-31 | -$107.00K 10-K · filed 2013-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |